Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.03 USD | -0.88% | -1.42% | -18.20% |
04-22 | Citigroup Starts Coverage on Evolent Health With Buy Rating, $40 Price Target | MT |
03-28 | Canaccord Genuity Trims Price Target on Evolent Health to $44 From $45, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.20% | 3.13B | |
+6.35% | 32.61B | |
+22.28% | 7.98B | |
+25.15% | 3.99B | |
-19.60% | 1.38B | |
-31.26% | 1.2B | |
+8.00% | 959M | |
-33.44% | 915M | |
-26.12% | 819M | |
-18.08% | 700M |
- Stock Market
- Equities
- EVH Stock
- News Evolent Health, Inc.
- Earnings Flash (EVH) EVOLENT HEALTH Posts Q3 EPS $0.30